Holen Sie sich die Stockscreener-App
13.68
1.16%
-0.16
Handel nachbörslich:
13.72
0.04
+0.29%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt FMC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$13.84
Offen:
$14.02
24-Stunden-Volumen:
2.27M
Relative Volume:
0.53
Marktkapitalisierung:
$1.71B
Einnahmen:
$4.17B
Nettoeinkommen (Verlust:
$1.46B
KGV:
1.1773
EPS:
11.62
Netto-Cashflow:
$493.00M
1W Leistung:
-8.62%
1M Leistung:
-19.48%
6M Leistung:
-63.31%
1J Leistung:
-62.62%
1-Tages-Spanne:
$13.61
$14.20
1-Wochen-Bereich:
$13.30
$15.11
52-Wochen-Spanne:
$12.17
$44.78
Fmc Corp Stock (FMC) Company Profile
Firmenname
Fmc Corp
Sektor
Branche
Telefon
215-299-6668
Adresse
2929 WALNUT STREET, PHILADELPHIA, PA
Compare FMC vs CTVA, NTR, CF, MOS, ICL
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FMC
Fmc Corp
|
13.68 | 1.73B | 4.17B | 1.46B | 493.00M | 11.62 |
|
CTVA
Corteva Inc
|
78.00 | 53.08B | 17.40B | 1.20B | 2.82B | 1.5836 |
|
NTR
Nutrien Ltd
|
73.59 | 35.87B | 26.89B | 2.30B | 1.93B | 4.6634 |
|
CF
Cf Industries Holdings Inc
|
104.71 | 16.33B | 6.74B | 1.70B | 1.71B | 8.2952 |
|
MOS
Mosaic Company
|
26.01 | 8.50B | 11.06B | 367.80M | 212.50M | 1.16 |
|
ICL
Icl Group Ltd
|
4.90 | 6.38B | 7.15B | 280.00M | 137.88M | 0.1749 |
Fmc Corp Stock (FMC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-11-11 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-10-31 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-10-31 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-10-30 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-10-14 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2025-06-23 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-25 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-03-13 | Eingeleitet | Goldman | Buy |
| 2025-02-14 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2025-02-07 | Herabstufung | UBS | Buy → Neutral |
| 2025-02-05 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-01-21 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-01-14 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-23 | Eingeleitet | Citigroup | Neutral |
| 2024-06-26 | Eingeleitet | Barclays | Equal Weight |
| 2024-03-01 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-02-12 | Herabstufung | Loop Capital | Buy → Hold |
| 2024-02-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2024-01-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-01-04 | Eingeleitet | ROTH MKM | Buy |
| 2023-12-14 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-12-07 | Herabstufung | Mizuho | Buy → Neutral |
| 2023-10-24 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-10-24 | Herabstufung | Goldman | Buy → Neutral |
| 2023-10-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-10-16 | Hochstufung | Vertical Research | Hold → Buy |
| 2023-09-25 | Herabstufung | Redburn Atlantic | Overweight → Neutral |
| 2023-09-05 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-21 | Eingeleitet | JP Morgan | Neutral |
| 2023-08-04 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2023-07-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-17 | Hochstufung | Redburn | Neutral → Buy |
| 2023-01-19 | Fortgesetzt | Wells Fargo | Overweight |
| 2023-01-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-15 | Hochstufung | Loop Capital | Hold → Buy |
| 2022-07-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-06-21 | Hochstufung | BofA Securities | Underperform → Buy |
| 2022-06-13 | Herabstufung | Redburn | Buy → Neutral |
| 2022-05-31 | Eingeleitet | Credit Suisse | Underperform |
| 2022-04-14 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-03-31 | Herabstufung | Monness Crespi & Hardt | Buy → Neutral |
| 2022-03-22 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-02-10 | Bestätigt | Citigroup | Buy |
| 2022-02-10 | Bestätigt | Mizuho | Buy |
| 2022-02-10 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2022-02-10 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-31 | Eingeleitet | Redburn | Buy |
| 2022-01-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-29 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-10-18 | Hochstufung | Loop Capital | Hold → Buy |
| 2021-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-24 | Herabstufung | Vertical Research | Buy → Hold |
| 2021-05-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-02-11 | Hochstufung | Monness Crespi & Hardt | Neutral → Buy |
| 2020-09-17 | Eingeleitet | UBS | Buy |
| 2020-03-26 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-03-13 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-10-16 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-10-16 | Eingeleitet | Wells Fargo | Outperform |
| 2019-09-18 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2019-08-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-08-02 | Hochstufung | Goldman | Neutral → Buy |
| 2019-08-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-06-13 | Fortgesetzt | Citigroup | Buy |
| 2019-05-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2019-04-18 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-03-21 | Bestätigt | Jefferies | Buy |
| 2019-03-08 | Fortgesetzt | Goldman | Neutral |
| 2018-11-14 | Eingeleitet | Buckingham Research | Buy |
| 2018-11-09 | Fortgesetzt | Loop Capital | Buy |
| 2018-11-05 | Fortgesetzt | Citigroup | Buy |
| 2018-11-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2018-05-14 | Hochstufung | Goldman | Neutral → Buy |
| 2018-05-04 | Hochstufung | Stephens | Equal-Weight → Overweight |
Alle ansehen
Fmc Corp Aktie (FMC) Neueste Nachrichten
FMC's GC Retired In 2025 With Over $6.6M In Compensation - Law360
FMC Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
FMC Corp. stock underperforms Monday when compared to competitors - MarketWatch
2 Words That Should Make Investors Think Twice About FMC Stock - The Motley Fool
FMC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
FMC Corporation declares 8-cent quarterly dividend - Investing.com
FMC Corporation Declares Quarterly Dividend - Finviz
Own FMC stock? An 8¢ per-share dividend is coming April 16 - Stock Titan
FMC appoints Michael Barry to board of directors By Investing.com - Investing.com Canada
FMC appoints Michael Barry to board of directors - Investing.com
FMC Corporation Announces Election of Michael F. Barry to Board of Directors - Finviz
Ex-Quaker Houghton CEO who led 27 deals joins FMC's board - Stock Titan
FMC Corp Stock Re-Rates On Cost Cuts And Lawsuits: Opportunity Or Value Trap? - AD HOC NEWS
FMC CORP SEC 10-K Report - TradingView
FMC Should I Buy - Intellectia AI
FMC Corp. stock underperforms Thursday when compared to competitors - MarketWatch
2 Top Bargain Stocks Ready for a Bull Run - The Motley Fool
Analysis of Insider Buying Activity at FMC Corp. - Intellectia AI
FMC at Bank of America Conference: Strategic Plans Unveiled - Investing.com
[Form 4] FMC CORP Insider Trading Activity - Stock Titan
FMC Corp Stock Rises — What Did The CEO Say To Drive Rally? - Asianet Newsable
FMC Considers Sale Process, Stock Rises 7% - Intellectia AI
FMC Corp. stock outperforms competitors on strong trading day - MarketWatch
FMC Corp. Hits Day High with 7.85% Surge in Strong Intraday Performance - Markets Mojo
FMC Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
FMC’s Rimisoxafen Receives Historic Dual Mode of Action Classification from HRAC - iGrow News
FMC Corporation Receives Industry's First Dual Mode of Action Herbicide Classification for Rimisoxafen - Finviz
Cardinal Health and FMC Corporation have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Bear of the Day: FMC Corp. (FMC) - The Globe and Mail
FMC Corporation Faces Revenue Decline and Strategic Options After Q4 Earnings Miss - Intellectia AI
FMC Corporation Faces Earnings Setbacks, Stock Under Pressure - Intellectia AI
Is FMC Stock a Buy Now or a Falling Knife? - Yahoo Finance
FMC Corp (FMC) Trading Down 3.63% on Feb 20 - GuruFocus
FMC and the Two-Engine Dilemma: When the Present Devours the Future - global-agriculture.com
FMC (NYSE:FMC) Given New $20.00 Price Target at Mizuho - Defense World
FMC and Corteva Partner to Expand Access to Fluindapyr Fungicide - MSN
FMC Corporation (NYSE:FMC) Short Interest Update - MarketBeat
Mizuho Maintains FMC Rating, Lowers Price Target to $20.00 | FMC Stock News - GuruFocus
FMC price target lowered to $20 from $21 at Mizuho - TipRanks
FMC Corporation (NYSE:FMC) Given Consensus Recommendation of "Reduce" by Brokerages - MarketBeat
FMC Corporation (NYSE:FMC) Given Consensus Recommendation of “Reduce” by Brokerages - Defense World
Mizuho Securities Maintains FMC Corp(FMC.US) With Buy Rating, Cuts Target Price to $20 - 富途牛牛
FMC Corporation: High-Risk Play In Fertilizers That I'm Unwilling To Enter (NYSE:FMC) - Seeking Alpha
Lessons for Life | Olivia Pfeiffer - Villanova University
Will FMC Corporation stock profit from fiscal stimulusJuly 2025 Analyst Calls & Verified Technical Trade Signals - mfd.ru
CEO Change: Can FMC Corporation be the next market leaderWatch List & Safe Entry Trade Reports - baoquankhu1.vn
FMC Posts $2.2 Billion Loss, Launches Strategic Review Including Possible Sale - PHILADELPHIA.Today
Is FMC Corporation stock heavily shortedWeekly Trend Recap & Risk Controlled Daily Plans - mfd.ru
FMC (FMC) expects tariff headwinds for Q1 as Q4 earnings slip - MSN
FMC Corp. stock underperforms Friday when compared to competitors - MarketWatch
FMC Corp.: How a Quiet Chemistry Powerhouse Became a Strategic Tech Product in Global Food Security - AD HOC NEWS
Finanzdaten der Fmc Corp-Aktie (FMC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.91%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):